CompoAtlas

Collagène marin, magnésium chélaté, MSM, silicium, vitamine D3 4000 + K2

Food supplement declared in France, decision dated 13 July 2026

Collagène marin, magnésium chélaté, MSM, silicium, vitamine D3 4000 + K2 (Bright Naturo) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: méthylsulfonate de méthane 600 mg per day, Bambusa bambos 14.71 mg per day, Magnesium, Vitamin C, Vitamin D. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Bright Naturo
Food business operator placing the product on the market
Bright Naturo Lab SL
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Sachet
Daily dose
1 sachet (5 gélules/comprimés) tous les 2 jours
Directions for use
Prendre 1 sachet (5 gélules/comprimés) tous les 2 jours avec de l'eau, de préférence au cours d'un repas.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Taking medication

Declaration 370756, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Bambusa bambos (L.) VossExudateOther dry extract14.71 mg

Substances

NamePer day
méthylsulfonate de méthane600 mg

Other active ingredients

NamePer day
Levure de bière inactivéenot declared
Collagène marinnot declared
Hyaluronate de sodiumnot declared
Ubiquinonenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
magnesium bisglycinateMagnesium250 mg300 mg
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg
cholecalciferolVitamin D100 µg (4,000 IU)5 µg (200 IU)
menaquinoneVitamin Kno limit (insufficient data)dose annulled by the French Council of State in 2011
zinc gluconateZinc25 mg15 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Contient du poisson, du gluten et des sulfites. Ne pas dépasser la dose journalière expressément recommandée. Les compléments alimentaires ne doivent pas se substituer à une alimentation variée et équilibrée ni à un mode de vie sain. Tenir hors de portée des enfants. Non destiné aux personnes de moins de 18 ans. Non recommandé pendant la grossesse ou l'allaitement ; en cas de grossesse, d'allaitement, de prise de médicaments ou de surveillance médicale, consultez un professionnel de santé avant utilisation et informez-le de votre consommation en raison d'éventuelles interactions ou contre-indications. Arrêter la prise en cas de réaction indésirable. Peut provoquer des réactions allergiques chez les personnes hypersensibles à un ingrédient. Conserver dans un endroit sec, frais et à l'abri de la lumière. Maintenir le récipient bien fermé. Ne pas consommer si l'opercule extérieur ou le bouchon est rompu. Aucune intoxication n'a été décrite aux doses habituelles.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • méthylsulfonate de méthane
    Read the warning, when it applies and the studies cited

    MSM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Kim et al. 2005).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Ubiquinone
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    Sources cited by Health Canada (2)
    • Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
    • Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    Sources cited by Health Canada (3)
    • Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
    • Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Bright Naturo

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Collagène marin, magnésium chélaté, MSM, silicium, vitamine D3 4000 + K2 (Bright Naturo): composition and regulation”, https://compoatlas.com/en/supplements/products/370756-collagene-marin-magnesium-chelate-msm-silicium-vitamine-d3-4, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line